751 Neo-X-Prime bispecific antibodies targeting CD40 and tumor antigens promote cross-presentation of tumor exosome-derived neoantigen and induce superior anti-tumor responses compared to CD40 mAb

• Peter Ellmark,
• Karin Hägerbrand,
• Mia Thagesson,
• Doreen Werchau,
• Anna Rosén,
• Karin Barchan,
• Anette Sundstedt,
• Adnan Deronic,
• Lill Ljung,
• Mattias Levin,
• Laura Von Schantz,
• Laura Varas,
• Anna Säll,
• Barnabas Nyesiga,
• Eva Lindqvist

Affiliations

Peter Ellmark

Aff2 grid.432080.dAlligator Bioscience AB Lund Sweden

Karin Hägerbrand

Aff1 grid.432080.dAlligator Bioscience AB Medicon Village, Scheelevägen 2 223 81 Lund Sweden

Mia Thagesson

Aff1 grid.432080.dAlligator Bioscience AB Medicon Village, Scheelevägen 2 223 81 Lund Sweden

Doreen Werchau

Aff1 grid.432080.dAlligator Bioscience AB Medicon Village, Scheelevägen 2 223 81 Lund Sweden

Anna Rosén

Aff1 grid.432080.dAlligator Bioscience AB Medicon Village, Scheelevägen 2 223 81 Lund Sweden

Karin Barchan

Aff1 grid.432080.dAlligator Bioscience AB Medicon Village, Scheelevägen 2 223 81 Lund Sweden

Anette Sundstedt

Aff1 grid.417652.3Active Biotech AB Lund Sweden

Adnan Deronic

Aff3 grid.4514.40000000109302361Immunology GroupLund University Lund Sweden

Lill Ljung

2Alligator Bioscience, Lund, Sweden

Mattias Levin

1Alligator Bioscience AB, Lund, Sweden

Laura Von Schantz

1Alligator Bioscience AB, Lund, Sweden

Laura Varas

1Alligator Bioscience AB, Lund, Sweden

Anna Säll

1Alligator Bioscience AB, Lund, Sweden

Barnabas Nyesiga

1Alligator Bioscience, Lund, Sweden

Eva Lindqvist

1Alligator Bioscience, Lund, Sweden